Inovelon Evropska unija - slovenščina - EMA (European Medicines Agency)

inovelon

eisai gmbh - rufinamide - epilepsija - antiepileptics, - inovelon je označen kot adjunctive terapija za zdravljenje epileptičnih, povezanih z lennox gastaut sindrom pri bolnikih 4 let in starejši.

Deltyba Evropska unija - slovenščina - EMA (European Medicines Agency)

deltyba

otsuka novel products gmbh - delamanid - tuberkuloza, odporna proti multidrugom - antimikobakterij - deltyba is indicated for use as part of an appropriate combination regimen for pulmonary multi-drug resistant tuberculosis (mdr-tb) in adults, adolescents, children and infants with a body weight of at least 10 kg when an effective treatment regimen cannot otherwise be composed for reasons of resistance or tolerability (see sections 4. 2, 4. 4 in 5. upoštevati je treba uradne smernice za ustrezno uporabo protibakterijsko agenti.